A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Healthy Adult Participants

Phase 1 Active not recruiting 20 enrolled AbbVie

NaSingle-groupOpen-labelBasic science

Summary

This study will assess the adverse events and how oral ABBV-932 moves through the body when given with oral Itraconazole in healthy Adults participants.

Timeline

Start: 2025-07-15
Primary completion: 2025-11
Completion: 2025-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ABBV-932	Unknown	—	Oral
Subject	Itraconazole	Small molecule	—	Oral

Indications

No indication recorded.